News Releases

November 26, 2019   NextCure to Present at Piper Jaffray 31st Annual Healthcare Conference

November 19, 2019   NextCure Announces Closing of Public Offering

November 14, 2019   NextCure Announces Pricing of Public Offering of Common Stock

November 12, 2019   NextCure Announces Proposed Public Offering of Common Stock

November 12, 2019   NextCure Reports Third Quarter 2019 Financial Results

November 9, 2019   NextCure Presents Updated Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of Society for Immunotherapy of Cancer (SITC) and Announces Initiation of Phase 2 Portion of the Trial

November 4, 2019   NextCure to Host and Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 2, 2019   NextCure Announces Promotion of Timothy Mayer, Ph.D., to Chief Operating Officer

October 1, 2019   NextCure to Present Clinical Data from NC318 Phase 1/2 Clinical Trial at 34th Annual Meeting of SITC

September 3, 2019   NextCure to Present at Morgan Stanley 17th Annual Global Healthcare Conference